Zhi Dai
- Molecular Biology top 10%
- Epidemiology top 5%
- Cancer Research top 5%
- Cell Biology top 5%
- Oncology top 10%
- Co-authors
- Jia FanAi‐Wu KeYing‐Hong ShiZhen‐Bin DingXiao‐Dong LuoJian ZhouBo HuiXiaoying Wang
- Topics
- Alkaloids: synthesis and pharmacology (10 papers)Berberine and alkaloids research (9 papers)RNA modifications and cancer (8 papers)
In The Last Decade
Zhi Dai
59 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Molecular Biology 975
- Epidemiology 653
- Cancer Research 370
- Cell Biology 275
- Oncology 241
Countries citing papers authored by Zhi Dai
This map shows the geographic impact of Zhi Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi Dai more than expected).
Fields of papers citing papers by Zhi Dai
This network shows the impact of papers produced by Zhi Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi Dai. The network helps show where Zhi Dai may publish in the future.
Co-authorship network of co-authors of Zhi Dai
This figure shows the co-authorship network connecting the top 25 collaborators of Zhi Dai. A scholar is included among the top collaborators of Zhi Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhi Dai. Zhi Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factorbreakdown → | 209 |
| 3 | 11 | |
| 4 | 12 | |
| 5 | 11 | |
| 6 | 17 | |
| 7 | 66 | |
| 8 | 32 | |
| 9 | 33 | |
| 10 | 28 | |
| 11 | 6 | |
| 12 | 35 | |
| 13 | 27 | |
| 14 | 17 | |
| 15 | 7 | |
| 16 | 20 | |
| 17 | 155 | |
| 18 | 11 | |
| 19 | 7 | |
| 20 | 236 |
About Zhi Dai
Zhi Dai is a scholar working on Pharmacology, Biochemistry and Pharmacology, having authored 59 papers that have together received 1.9k indexed citations. Recurring topics across this work include Alkaloids: synthesis and pharmacology (10 papers), Berberine and alkaloids research (9 papers) and RNA modifications and cancer (8 papers). The work is most often cited by research in Cancer Research (370 citations), Epidemiology (653 citations) and Cell Biology (275 citations). Zhi Dai has collaborated with scholars based in China, Pakistan and India. Frequent co-authors include Jia Fan, Ai‐Wu Ke, Ying‐Hong Shi, Zhen‐Bin Ding, Xiao‐Dong Luo, Jian Zhou, Bo Hui, Xiaoying Wang, Guo‐Ming Shi and Shuang–Jian Qiu. Their work appears in journals such as Journal of Biological Chemistry, Cancer Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.